1887

n South African Medical Journal - Outcomes of TB/HIV co-infected patients presenting with antituberculosis drug-induced liver injury : research

Volume 105, Issue 5
  • ISSN : 0256-9574
  • E-ISSN: 2078-5135
USD

 

Abstract

South Africa has a significant burden of tuberculosis (TB). Anti-TB drug-induced liver injury (TB DILI) is one of the most serious adverse events that can arise from TB treatment (TBT). There are limited data on TB DILI among HIV-infected patients and those on antiretroviral therapy (ART).


To describe characteristics of HIV-infected patients presenting with TB DILI and the proportion reintroduced on standard or modified TBT after DILI.
This was a retrospective study of TB/HIV co-infected patients with DILI between 1 July 2009 and 30 September 2012. The primary focus of interest was HIV-infected patients with TB DILI on ART (ART/TB DILI) v. not on ART (TB DILI).
A total of 94 patients were included, 41 with TB DILI and 53 with ART/TB DILI. Compared with patients with TB DILI, patients with ART/TB DILI were more likely to present with symptomatic DILI (71.2% v. 51.2%; =0.03) and had a lower median alanine aminotransferase level at diagnosis (89 IU/L v. 118 IU/L; =0.008), a lower rate of ALT decline (-23 IU/L v. -76 IU/L; =0.047) and longer duration of TBT at DILI diagnosis (53 days v. 11 days; < 0.001). In 71.8% of patients, standard TBT was reintroduced. More patients with ART/TB DILI than TB DILI required modified TBT (37.2% v.17.1%; =0.05; crude odds ratio 2.17; 95% confidence interval 0.95 - 4.96). The rate of death/loss to follow-up was higher in the ART/TB DILI group (18.9% v. 14.5%).
A significant number of TB/HIV co-infected patients were not able to tolerate standard TBT. Furthermore, ART appears to complicate TBT, with relatively fewer patients reintroduced on standard TBT.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/m_samj/105/5/EJC170456
2015-05-01
2017-10-19

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error